/
/
/

Transgene Biotek Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)2.82
Volume (₹)31,396.00
High (₹)2.82
Upper Circuit3.32
Low (₹)2.65
Lower Circuit2.22
Prev Close2.77
52W High (₹)4.50
Price2.70
52W Low (₹)1.83

Share Market Cap & Key Ratios Overview

M.Cap (₹)20.99 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity1.45
Price to Book2.53
Book Value1.32
EPS (TTM)-0.21
Face Value10.00
ROE (%)-6.52

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SAGILITY-ANSE
SYNGENE-ANSE
INDGN-ANSE
IGIL-ANSE
NESCO-ANSE
JUSTDIAL-ANSE
LATENTVIEW-ANSE
CMSINFO-ANSE
MEDIASSIST-ANSE
AWFIS-ANSE
TRABI-XNSE
LTP
1W Low
1W High
Market cap (₹)
46.74+0.34 (0.73%)
45.85
47.47
21,885Cr
395.85-7.55 (-1.87%)
395.10
407.50
16,169Cr
601.65+23 (3.97%)
579.95
616
14,458Cr
324.55-14.8 (-4.36%)
321.35
346.50
14,065Cr
1053+4.7 (0.45%)
1028.80
1065.90
7,366Cr
692.35-12.3 (-1.75%)
688.90
734
5,918Cr
267.45-13.05 (-4.65%)
265.20
278.60
5,504Cr
242.7+0.15 (0.06%)
238.35
253.95
3,918Cr
340.65+7.15 (2.14%)
328
348.50
2,567Cr
261.95+8.4 (3.31%)
250.95
268.70
1,835Cr
2.7-0.2 (-6.90%)
2.60
2.95
21Cr

Key Highlights of Transgene Biotek Ltd Balance Sheet

Transgene Biotek Ltd balance sheet discloses shareholders' funds of ₹75.77Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹75.77Cr, and the reserves and surplus of the company is -₹83.32Cr.

The company has its non-current liabilities with total liabilities of ₹34.2Cr as of 2025-03-31.

The current liabilities are ₹12.62Cr as of 2025-03-31. At the same time, current assets are ₹1.26Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹9.5Lakh and tangible assets of ₹7.96Cr, provided in the Transgene Biotek Ltd financial statements.